Sponsor Collaborators Module
The Sponsor Collaborators Module contains information about the sponsors and collaborators involved in the clinical trial. This includes lead sponsor details, responsible party information, investigator information, and collaborator organizations that are supporting or conducting the study.
Sponsor Collaborators Module path is as follows:
Study -> Protocol Section -> Sponsor Collaborators Module -> Collaborators
Sponsor Collaborators Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 10:51 PM
NCT ID:
NCT04843267
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Study:
NCT04843267
Study Brief:
A Multi-center, Non-randomized, Open-label Phase II Clinical Study on the Treatment of Newly Diagnosed Advanced Hodgkin's Lymphoma With PD-1 Antibody (Tislelizumab) Combined With AVD Regimen (Doxorubicin, Vindesine, Dacarbazine) Under the Guidance of PET/CT
Protocol Section:
NCT04843267
Collaborators (If Any):